Díaz-Guerra Guillermo Martínez, Gil-Fraguas Lourdes, Jódar Esteban, Meneu Juan Carlos, García Elena, Gómez Miguel Angel, Moreno Enrique, Hawkins Federico
Department of Endocrinology, University Hospital 12 de Octubre, Madrid, Spain.
J Clin Densitom. 2006 Oct-Dec;9(4):469-74. doi: 10.1016/j.jocd.2006.06.001. Epub 2006 Jul 28.
Bone loss is one of the most common complications after solid-organ transplantation, but it is frequently under-diagnosed. Our purpose was to evaluate quantitative ultrasound of calcaneus (QUS) in comparison with dual-energy X-ray absorptiometry (DXA) to identify transplant recipients with osteoporosis. We have cross-sectionally evaluated 140 transplant recipients (85 liver and 55 cardiac transplantations; mean age: 53.6 years, time since transplantation: 67.9 months). Devices used were Hologic 4500 QDR for DXA measurements and Sahara Clinical Sonometer (Hologic Inc, Bedford, MA) for calcaneal QUS. Quantitative ultrasound index (QUI) was calculated from speed of sound (m/s) and broadband ultrasonic attenuation (dB/MHz). QUI T-score and bone mineral density (BMD) T-score (spine and hip) were obtained from Spanish normative data. According to World Health Organization criteria, defined either at lumbar spine or femoral neck, 61% of the females had osteopenia and 32% had osteoporosis, whereas 52% of the males had osteopenia and 11% had osteoporosis. Calcaneal QUS parameters (speed of sound, broadband ultrasonic attenuation, and QUI) were positively correlated with lumbar and femoral BMD (p<0.001). In receiver operator characteristic analysis, a T-score QUI<or=-1.4 standard deviation (SD) had 68% sensitivity and 72% specificity for osteoporosis diagnosis by DXA criteria. However, to obtain maximal sensitivity (5% of false-negative), QUI T-score cutoff should be -0.6 SD, but specificity drops to 42%. In conclusion, a positive correlation exists between lumbar and femoral BMD and QUS parameters in long-term liver or cardiac transplant recipients. QUS could be recommended for screening of osteoporosis in long-term transplanted patients.
骨质流失是实体器官移植后最常见的并发症之一,但往往诊断不足。我们的目的是评估跟骨定量超声(QUS)与双能X线吸收法(DXA)相比,用于识别骨质疏松症移植受者的情况。我们对140名移植受者进行了横断面评估(85例肝移植和55例心脏移植;平均年龄:53.6岁,移植后时间:67.9个月)。使用的设备是用于DXA测量的Hologic 4500 QDR和用于跟骨QUS的Sahara Clinical Sonometer(Hologic公司,贝德福德,马萨诸塞州)。根据声速(m/s)和宽带超声衰减(dB/MHz)计算定量超声指数(QUI)。QUI T评分和骨密度(BMD)T评分(脊柱和髋部)来自西班牙标准数据。根据世界卫生组织标准,在腰椎或股骨颈处定义,61%的女性有骨质减少,32%有骨质疏松,而52%的男性有骨质减少,11%有骨质疏松。跟骨QUS参数(声速、宽带超声衰减和QUI)与腰椎和股骨BMD呈正相关(p<0.001)。在接受者操作特征分析中,根据DXA标准,QUI T评分≤-1.4标准差(SD)对骨质疏松症诊断的敏感性为68%,特异性为72%。然而,为了获得最大敏感性(5%的假阴性),QUI T评分临界值应为-0.6 SD,但特异性降至42%。总之,长期肝或心脏移植受者的腰椎和股骨BMD与QUS参数之间存在正相关。QUS可推荐用于长期移植患者骨质疏松症的筛查。